Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease.

Por Ondrej Fiala, Daniela Zahorakova, Lenka Pospisilova, Jana Kucerova, Milada Matejckova, Pavel Martasek, Jan Roth, Evzen Ruzicka
Publicado em 2014-01-01

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Anal...

Por Ondrej Fiala, Jindrich Finek, Alexandr Poprach, Bohuslav Melichar, Jindrich Kopecký, Milada Zemanova, Katerina Kopeckova, Tomas Mlcoch, Tomas Dolezal, Lenka Capkova, Tomas Buchler
Publicado em 2020-03-01

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry

Por Alexandr Poprach, Milos Holanek, Renata Chloupkova, Radek Lakomy, Michal Stanik, Ondrej Fiala, Bohuslav Melichar, Katerina Kopeckova, Milada Zemanova, Igor Kiss, Igor Penka, Julia Bohosova, Tomas Buchler
Publicado em 2020-10-01

Eye movements in ephedrone-induced parkinsonism.

Por Cecilia Bonnet, Jan Rusz, Marika Megrelishvili, Tomáš Sieger, Olga Matoušková, Michael Okujava, Hana Brožová, Tomáš Nikolai, Jaromír Hanuška, Mariam Kapianidze, Nina Mikeladze, Nazi Botchorishvili, Irine Khatiashvili, Marina Janelidze, Tereza Serranová, Ondřej Fiala, Jan Roth, Jonas Bergquist, Robert Jech, Sophie Rivaud-Péchoux, Bertrand Gaymard, Evžen Růžička
Publicado em 2014-01-01